Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack | Zendy

George Ntaios | Zendy; Vasileios Papavasileiou | Zendy; Dimitrios Sagris | Zendy; Konstantinos Makaritsis | Zendy; Konstantinos Vemmos | Zendy; Thorsten Steiner | Zendy; Patrik Michel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack

Author(s) -

George Ntaios,

Vasileios Papavasileiou,

Dimitrios Sagris,

Konstantinos Makaritsis,

Konstantinos Vemmos,

Thorsten Steiner,

Patrik Michel

Publication year - 2018

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.117.020030

Subject(s) - medicine , patent foramen ovale , stroke (engine) , odds ratio , paradoxical embolism , confidence interval , myocardial infarction , atrial fibrillation , cardiology , embolism , randomized controlled trial , surgery , migraine , mechanical engineering , engineering

Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ovale (PFO) closure versus medical treatment in patients with cryptogenic stroke or transient ischemic attack (TIA). Recently, new evidence from randomized trials became available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research